SEKISUI Diagnostics provides diagnostic products and services, including clinical chemistry reagents, point-of-care testing, and biopharma services. The company is involved in the development, manufacturing, and supply of various diagnostic solutions.

SEKISUI Diagnostics

Biotechnology Research

BioProduction by SEKISUI

SEKISUI Diagnostics | 13,843 followers on LinkedIn. Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan.
Our workforce spans six sites located in four countries.

Embedded Software Consultant @ SEKISUI Diagnostics | Yocto Project, Defect Management

Jean-Pierre Sainfeld

Sr. Manager, HR Business Partner at Sekisui Diagnostics, LLC

Jenny Clark, SPHR, CCP

Karen Choquet

Eyvonne Therrien

Artificial intelligence is here. It's a tool that can provide tremendous opportunities and challenging obstacles for the care continuum. The major question facing healthcare organizations is how to harness this technology ethically and efficiently. Read More: https://hubs.ly/Q02Yf_6h0 #Healthcare #medicine #pointof care

On this World Diabetes Day, we emphasize the importance of holistic health for those affected by diabetes. Let's unite in raising awareness, supporting those impacted, and advocating for accessible, quality care for all. #WorldDiabetesDay #HealthAndWellbeing

Medica 2024 is in full swing! Come see us in Hall 1/D59. #MEDICA2024

The excitement continues on the second day of the JIB conference in Paris. Thank you to everyone who stopped by the SEKISUI Diagnostics stand to explore the OSOM® product range. #JIB2024 #InnovationInHealthcare #OSOM

November is Pancreatic Cancer Awareness Month At SEKISUI Diagnostics, we're committed to empowering healthcare professionals with the knowledge and tools they need to support early detection and improve patient outcomes. Together, through shared knowledge and continuous advancement, we can make meaningful strides against pancreatic cancer. #PancreaticCancerAwareness

We are thrilled to announce our participation in the JIB conference in Paris on November 7th and 8th. Visit us at stand 7 to discover more about our OSOM® product range. #JIB2024 #Innovation #OSOM

Medica 2024 is almost here! Come visit us in Dusseldorf, Germany as our Global Commercial Team will be there to discuss our products and services and how we can enhance your diagnostic offering. We would love to see you! Hall 1/D59 https://lnkd.in/djF85sP

Two weeks after InnoTrans our SEKISUI team shares insights of our presence, their on-site experiences and the importance of being at the biggest railway fair in the world, where the SEKISUI Team was exhibiting the FFU Railway Synthetic Sleepers. 🚆 Find out more about our lightweight and durable sleepers with our experts Clemens Bretschneider , Thorsten Delfs and Patrick Childs . #oneSEKISUI #SEKISUI #InnoTrans #Railway #FFU #FFUSleepers #sleepers #exhibition SEKISUI FFU Railway Technology

SEKISUI EUROPE

We are thrilled to be exhibiting at MEDEXPO Africa 2024 in Tanzania! The MEDEXPO Africa exhibition is the largest trade event for the healthcare and medical sector in the region. Join us at stand B185A to learn more about our point-of-care products. #Medexpo #AfricaHealthcare #OSOM

Metric
Company Name	SEKISUI Diagnostics
Symbol
MSH ID	COM:SEKISUIDIAGNOSTICS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Diagnostics
Country	US
Stage
Employee Count
Website	sekisuidiagnostics.com
LinkedIn	sekisui-diagnostics-llc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	2.89K
Web Traffic Growth	-0.61
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SEKI

COM:SEKISUIDIAGNOSTICS

SEKISUI Diagnostics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue